32
Views
5
CrossRef citations to date
0
Altmetric
Review

Immunoscreening protocols for the identification of clinically useful antibodies and antigens

, &
Pages 373-389 | Published online: 23 Feb 2005

Bibliography

  • GLASSY M, MCKNIGHT M: A drug discovery program utilizing the human immune response. Curr. Opin. In-vest. Drug (1993) 2:853–858.
  • GLASSY M, MCKNIGHT M: Pharming the human lymph node. Exp. Opin. Invest. Drugs (1994) 3(101057–1060.
  • MUKERJEE S, NASOFF M, MCKNIGHT M, GLASSY M: Char-acterization of human IgG1 monoclonal antibody gan-gliosides expressed on tumor cells. Cancer Res. (1998). (Submitted.)
  • MCKNIGHT ME, MUKERJEE S, NASOFF M, GASKINS C, GLASSY M: Isotype directed enrichment of B cells by magnetic beads in the generation of immunoreactive human monoclonal antibodies. Hybridoma (1996) 15:255–261.
  • KODA K, GLASSY MC, CHANG H: Generation of human monoclonal antibodies against colon cancer. Arch. Surg. (1990) 125:1591–1597.
  • MCKNIGHT ME, KODA K, DEBOER K, GLASSY MC: Hu-man monoclonal antibodies to nuclear antigens. Hu-man Antibod. Hybridomas (1990) 1:77–82.
  • MUKERJEE S, MCKNIGHT M, NASOFF M, GLASSY M: Co-expression of tumor antigens and their modulation by pleiotrophic modifiers enhance targeting of human monoclonal antibodies to pancreatic carcinoma. Hu-man Antibod. (1998). (In Press.)
  • BEAVIS AJ, PENNLINE KJ: Detection of cell surface anti-gens using antibody-conjugated fluorospheres (ACF): application for six color immunofluorescence. Bio-techniques (1996) 21:498–503.
  • BAUER FA, WEAR DJ, ANGRITT P, LO SC: Mycoplasmafermentas (incognitus strain) infection in the kidneys of patients with acquired immunodeficiency syn-drome and associated nephropathy: a light micro-scopic, immunohistochemical and ultrastructural study. Hum. Pathol. (1991) 22:63–69.
  • CLEGHORN AG, WILKINSON RG: The IUCD associatedincidence of Actinomyces israelli in the female genital tract. Aust. NZ J. Obstet. Gynaecol. (1989) 29:445–449.
  • WALLENBECK I, DREBORG S, ZETTERSTROM-EINARSSON R: Aspergillus fumigatus specific IgE and IgG antibod-ies for diagnosis of Aspergillus-related lung diseases. Allergy (1991) 46:372–378.
  • NUSSLEIN HG, ZIMMERMAN T, BAUM M et al.: Improved in vitro diagnosis of allergy to Alternaria tenius and Cladosporium hebarum. Allergy (1987) 42:414–422.
  • YEN CM, CHEN ER: Detection of antibodies to Angios-trongylus cantonensis in serum and cerebrospinal fluid of patients with eosinophilic meningitis. Int. J. Parasitol. (1991) 21:17–21.
  • SHIH HH, CHEN SN: Immunodiagnosis of angios-trongyliasis with monoclonal antibodies recognizing a circulating antigen of mol wt. 91,000 from Angios-trongylus cantonensis. Int. J. Patasitol. (1991) 21:171–177.
  • BLASBERG RG, NAKAGAWAH H, BOURDON MA, GROOTHUIS DR, PATLAK CS: Regional localization of a glioma-associated antigen defined by monoclonal an-tibody 8106 in vivo: kinetics and implications for diag-nosis and therapy. Cancer Res. (1987) 47:4432–4443.
  • VAN NAGELL JR, KIM E, CASPER S et al.: Radioimmunode-tection of primary and metastatic ovarian cancer using radiolabeled antibodies to carcinoembryonic antigen. Cancer Res. (1980) 40:502–506.
  • EPENETOS AA, SHEPHERD J, BRITTON KE et al.: 125[11Ra-dioiodinated antibody imaging of occult ovarian can-cer. Cancer (1985) 55:984–987.
  • POELS LG, PETERS D, CAN MEGEN Y et al.: Monoclonal antibody against human ovarian tumor-associated an-tigens. J. Natl. Cancer Inst. (1986) 76:781–791.
  • HNATOWITCH DJ, GRIFFIN TW, MCGANN J et al.: Radio-immunodetection of ovarian and other tumors in pa-tients using indium labeled 0C125 antibody; a comparison with 19–9 antibody. International Confer-ence on Monoclonal Antibody: Immunoconjugates for Can-cer. San Diego, CA, USA (1986):40.
  • PIETERSZ GA, WENJUN L, SUTTON VR et al.: In vitro and in vivo antitumor activity of a chimeric anti-CD19 anti-body. Cancer Immunol Immunother. (1995) 41:53–60.
  • KARUBE Y, KATSUNO K, TAKATA J, MATSUNAGA K: Ra-dioimmunoscintigraphy using technitium-99m-labeled parental mouse and mouse-human chimeric antibodies to carcinoembryonic antigen in athymic nude mice bearing tumor. Nuclear Med. Biol. (1996) 23:753–759.
  • STEFFENS MG, BOERMAN OC, OOSTERWIJK-WAKKA JC et al. Targeting of renal cell carcinoma with iodine 131 labeled chimeric monoclonal antibody G250. J. Clin. Oncol. (1997) 15:1529–1537.
  • HARUNO M, KUROKI M, MATSUNAGA K et al.: Tumor specific accumulation of 1251 labeled mouse-human chimeric anti-CEA antibody in a xenografted human cancer model demonstrated by whole-body autora-diography and immunostaining. Nuclear Med. Biol. (1996) 23:821–826.
  • KAMIGAKI T, YAMAMOTO M, OHNAYAGI H, SAITOH Y: Radiolocalization of pancreatic carcinoma xenografts in nude mice with radiolabeled chimeric Fab frag-ments of anti-carcinoembryonic antigen monoclonal antibody A10. Pancreas (1995) 10:258–264.
  • QI Y, MATTE G, WILKINSON A, JIM X: High affinity chi-meric anti-colorectal carcinoma antibody correlated to enhance tumor targeting in biodistribution and im-aging. J. Cancer Res. Clin. Oncol. (1993) 120:57–62.
  • KODA K, YASUTOMI J, NAKAJIMA N, MCKNIGHT M, GLASSY M: Radioimmunoscintigraphy of adenocarci-nomas using Monopharm-C, a human monoclonal an-tibody conjugated to indium 111. Proc. Am. Soc. Clin. Oncol. (1997) 16:431a.
  • BEHR TM, GOLDENBERG DM, SCHEELE JR, WOLF FG, BECKER W: Clinical relevance of immunoscintigraphy with 99mTc-labeled anti-CEA antigen binding frag-ments in the follow up of patients with colorectal car-cinoma. Assessment of surgical resectability with a combination of conventional imaging methods. Deut-sche Medizin. Wochen. (1997) 122:463–470.
  • CASEY JL, KING DJ, CHAPLIN LC et al: Preparation, char-acterization and tumor targeting of cross-linked diva-lent and trivalent anti-tumor Fab' fragments. Br. J Cancer (1996) 74:1397–1405.
  • SAMUELSSON A, CHIODI F, OHMAN P et al.: Chimeric macaque/human Fab molcules neutralize simian im-muodeficiency virus. Virology (1995) 207:495–502.
  • BEGENT RH, VERHAAR MJ, CHESTER KA et al.: Clinical evidence of efficient tumor targeting based on single-chain Fv antibody selected from a combinatorial li-brary. Nature Med. (1996) 2:979–984.
  • KING DJ, TURNER A, FARNSWORTH AP et al.: Improved tumor targeting with chemically cross-linked recom-binant antibody fragments. Cancer Res. (1994) 54:6176–6185.
  • GADE W, LEDMAN DW, WETHINGTON R, YI A: Serologi-cal responses to various Coccidioides antigen prepara-tions in a new enzyme immunoassay. J. Clin. Microbic)]. (1992) 30:1907–1912.
  • CERBAN FM, GEA S, MENSO E, VOTTERO-CIMA E: Chagas disease: IgG isotypes against Trypanosoma cruzi cyto-sol acidic antigens in patients with different degrees of heart damage. Clin. Immunol. Immunopathol. (1993) 67:25–30.
  • POUSSIN M, FUENTES V, CORBEL C, PRIN L, EB F, ORFILAJ: Capture-ELISA: a new assay for the detection of im-munoglobulin M isotype antibodies using Chlamydia trachomatis antigen. J. Immunol. Methods (1997) 204:1–12.
  • YEN CM, CHEN ER, HOU MF, CHANG JH: Antibodies of different immunoglobulin isotypes in serum and bile of patients with clonorchiasis. Ann. Trop. Med. Parasitol. (1992) 86:263–269.
  • CARNI C, FRATAZZI C, BARBATO M: IgG autoantibody to IgE in atopic patients. Ann. Allergy (1988) 60:48–52.
  • ESPANOL T, CATALA M, HERNANDEZ M et al.: Develop-ment of a common variable immunodeficiency in IgA-deficient patients. Clin. Immunol. Immunopathol. (1996) 80:333–335.
  • BRINKMANN U, WEBBER K, DICARLO A et al.: Cloning and expression of the recombinant Fab fragment of monoclonal antibody K1 that reacts with mesothelin present on mesotheliomas and ovarian cancers. Int. J. Cancer (1997) 71:638–644.
  • UYAMA I, KUMAI K, YASUDA T et al.: Improvement of therapeutic effect by using Fab() fragment in the treat-ment of carcinoembryonic antigen-positive human solid tumors with adriamycin-entrapped immunoli-posomes. Jap. J. Cancer Res. (1994) 85:434–440.
  • LECHNER P, LIND P, BINTER G, CESNIK H: Anticarci-noembryonic antigen immunoscintigraphy with 99mTc-FabO fragment (Immu 4) in primary and recur-rent colorectal cancer. A prospective study. Disease Co-lon Rectum (1993) 36:930–935.
  • LIANG M, CHU YK, SCHMALJOHN C: Bacterial expres-sion of neutralizing mouse monoclonal antibody Fab fragments to Hantaan virus. Virology (1996) 217:262–271.
  • SAMUELSSON A, CHIODI F, OHMAN P et al.: Chimeric macaque/human Fab molecules neutralize simian im-munodeficiency virus. Virology (1995) 207:495–502.
  • PLUCKTHUN A, PACK P: New protein engineering ap-proaches to multivalent and bispecific antibody frag-ments. Immunotechnology (1997) 3:83–105.
  • RHIENNECKER M, HARDT C, ILAG LL et al.: Multivalentantibody fragments with high functional affinity for a tumor-associated carbohydrate antigen. J. Immunol. (1996) 157:2989–2997.
  • KERSCHBAUME RJ, HIRSCHL S, KAUFMANN A et al.: Single-chain Fv fusion proteins suitable as coating and detecting reagents in a double antibody sandwich enzyme-linked immunoassay. Anal. Biochem. (1997) 249:219–227.
  • KIPRIYANOV SM, KUPRIYANOVA OA, LITTLE M, MOLD-ENHAUER G: Rapid detection of recombinant antibody fragments directed against cell-surface antigens by flow cytometry. J. Immunol. Meth. (1996) 196:51–62.
  • THIRION S, MOTMANS K, HEYLIGEN H et al.: Mono and bispecific single-chain antibody fragments for cancer therapy. Eur. J. Cancer Preven. (1996) 5:507–511.
  • LILLEY GG, DOLEZAL O, HILLYARD CJ, BERNARD C, HUD-SON PJ: Recombinant single chain antibody peptide conjugates expressed in Escherichia coif for the rapid diagnosis of HIV. J. Immunol. Meth. (1994) 171:211–226.
  • JIANG W, BONNERT TP, VENUGOPAL K, GOULD EA: A single chain antibody fragment expressed in bacteria neutralizes tick-borne flaviviruses. Virology (1994) 200:21–28.
  • JANNOT CB, HYNES NE: Characterization of scFv-421, asingle chain antibody targeted to p53. Biochem. Bio-phys. Res. Commun. (1997) 230:242–246.
  • SCHMIDT M, HYNES NE, GRONER B, WELS W: A bivalent single-chain antibody toxin specific for ErbB-2 and the EGF receptor. Int. J. Cancer (1996) 65:538–546.
  • HOLLIGER P, BRISSINCK J, WILLIAMS RL, THIELEMANS K, WINTER G: Specific killing of lymphoma cells by cyto-toxic T cells mediated by a bispecific diabody. Prot. En-gineer. (1996) 9:2099–305.
  • HU S-Z, SHIVELY L, RAUBITSCHEK A et al.: Minibody: a novel engineered anti-carcinoembryonic antigen anti-body fragment (single-chain Fv-CH3) which exhibits rapid, high level targeting of xenografts. Cancer Res. (1996) 56:3055–3061.
  • HAMMERS-CASTERMAN C, ATARHOUCH T, MUYLDER-MANS S et al.: Camel antibody response is devoid of light chains. Nature (1993) 363:446–448.
  • CAI X, GAREN A: Comparison of fusion phage librariesdisplaying VII or single chain Fv antibody fragments derived from the antibody repertoire of a vaccinated melanoma patient as a source of melanoma specific targeting molecules. Proc. Natl. Acad. Sci. USA (1997) 94:9261–9266.
  • HAMMARSTROM S, SHIVELY JE, PAXTON RJ et al.: Anti-genic sites in carcinoembryonic antigen. Cancer Res. (1989) 49:4852–4859.
  • KUROKI M, KUROKI M, KOGA Y et al.: Monoclonal anti-bodies to carcinoembryonic antigen: a systematic analysis of antibody specificities by using related nor-mal antigens and evidence for allotypic determinants on carcinoembryonic antigen. J. Immunol. (1984) 133:2090–2098.
  • KUROKI M, GREINER JW, SIMPSON JF et al.: Serologicmapping and biochemical characterization of the car-cinoembryonic antigen epitopes using fourteen dis-tinct monoclonal antibodies. Int. J. Cancer (1989) 44:208–215.
  • ABELEV GI, PEROVA SD, KHRAMKOVA NI et al.: Produc-tion of embryonal beta-globulin by transplantable mouse hepatomas. Transplantation (1963) 1:174–180.
  • MURARO R, KUROKI M, WUNDERLICH D et al.: Genera-tion and characterization of B72.3 second generation monoclonal antibodies reactive with the tumor associ-ated glycoprotein-72 antigen. Cancer Res. (1988) 48:4588–4595.
  • THOR A, OHUCHI N, SZPAK CA et al.: Distribution of on-cofetal antigen tumor-associated glycoprotein-72 de-fined by monoclonal antibody B72.3. Cancer Res. (1986) 46:3118–3128.
  • HILKENS J, BUIJS F, HILGERS J et al.: Monoclonal anti-bodies against human milk-fat globule membranes de-tecting differentiation antigens of the mammary gland and its tumors. Int. J. Cancer (1984) 34:197–206.
  • GRIFFIN JD, LINCH D, SABBATH K et al: A monoclonal antibody reactive with normal and leukemic human myeloid progenitor cells. Leuk. Res. (1984) 8:521–527.
  • MURARO R, WUNDERLICH D, THOR A et al.: Immuno-logical characterization of a novel human colon asso-ciated antigen (CAA) by a monoclonal antibody. Int. J. Cancer (1987) 39:34–42.
  • MENDELSOHN J: Growth factor receptors as targets for antitumor therapy with monoclonal antibodies. Prog. Allergy (1988) 45:147–156.
  • HOPKINS CR, TROWBRIDGE IS: Internalization and processing of transferrin and the transferrin receptor in human carcinoma A431 cells. J. Cell Biol. (1983) 97:508–516.
  • MASUI H, KAWAMOTO T, SATO JD et al.: Growth inhibi-tion of human tumor cells in athymic mice by epider-mal growth factor receptor monoclonal antibodies. Cancer Res. (1984) 44:1002–1009.
  • WALDMANN TA: The structure, function and expres-sion of interleukin-2 receptors on normal and malig-nant lymphocytes. Science (1986) 232:727–731.
  • BACUS SS, STANCOVSKI I, HUBERMAN E et al.: Tumor-inhibitory monoclonal antibodies to the HER-2/Neu receptor induce differentiation of human breast can-cer cells. Cancer Res. (1992) 52:2580–2588.
  • DREBIN JA, LINK VC, GREENE MI: Inhibition of tumor growth by a monoclonal antibody reactive with an oncogene-encoded tumor antigen. Proc. Natl. Acad. Sci. USA (1986) 83:9129–9134.
  • DREBIN JA, LINK VC, GREENE MI: Monoclonal antibod-ies specific for the neu oncogene product directly me-diate anti-tumor effects in vivo. Oncogene (1988) 2:387–393.
  • JERNE NK: Towards a network theory of the immune system. Ann. Immunol. (1974) 125:373–389.
  • KENNEDY RC, DREESMEN GR, KOHLER H: Vaccines util-izing internal image anti-idiotypic antibodies that mimic antigens of infectious organisms. Biotechniques (1985) 3:404–410.
  • LEE VK, HELLSTROM KE, NEPOM GT: Idiotypic interac-tions in immune responses to tumor associated anti-gens. Biochem. Biophys. Acta (1986) 865:127–139.
  • HERLYN D, WETTENDORF M, SCHMOLL E et al.: Anti-idiotypic immunization of cancer patients: modula-tion of the immune response. Proc. Natl. Acad. Sci. USA (1987) 84:8055–8059.
  • MITTLEMAN A, CHEN ZJ, YANK H, WONG GY, FERRONE S: Human high molecular weight melanoma-associated antigen (HMW-MAA) mimicry by mouse anti-idiotypic monoclonal antibody MK2-23: induc-tion of humoral anti-HMW-MAA immunity and prolon-gation of survival in patients with stage IV melanoma. Proc. Natl. Acad. Sci. USA (1992) 89:466–470.
  • KOHLER G, MILSTEIN C: Continuous cultures of fusedcells secreting antibody of pre-defined specificity. Na-ture (1975) 256:495–498.
  • CERIANI RL, SASAKI M, SUSSMAN H, WARA WM, BLANKEW: Circulating human-mammary epithelial antigens in breast cancer. Proc. Natl. Acad. Sci. USA (1982) 79:5420–5424.
  • CERIANI RL, ROSENBAUM EH, CHANDLER M et al.: Role ofcirculating human mammary epithelial antigens (HME-Ags) as serum markers for breast cancer. In: Tu-mour Markers and Their Significance in the Management of Breast Cancer. Ip C, Liss AR, (Eds.), NY, USA (1986):3–19.
  • JANOSSY G, AMLOT P: Immunofluorescence and im-munihistochemistry. In: Lymphocytes - A Practical Ap-proach. GGB Klaus (Ed.), IRL Press, Oxford, UK (1987):67–108.
  • BROWMAN GP, NEAME PB, SOAMBOONSRUP P: The con-tributions of cytochemistry and immunophenotyping to the reproducibility of the FAB classification in acute leukemia. Blood (1986) 68:900–905.
  • FOON KA, TODD RF: Immunologic classification of leu-kemia and lymphoma. Blood (1986) 68:1–31.
  • MEEKER TC, MILLER R, LINK M et al.: A unique human B lymphocyte antigen defined by a monoclonal anti-body. Hybridoma (1984) 3:305–320.
  • BOROWITZ MJ, DOWELL BL, BOYETT JM et al.: Mono-clonal antibody definition of T cell acute leukemia: a pediatric oncology group study. Blood (1985) 65:785–788.
  • GELDER FB, MORRIS DM, GOODWILL WJ, FOWLER MR: Evaluation of the pancreatic oncofetal antigen (PGA) in patients with carcinoma and benign disease. Tu-mour Biol. (1984) 5:98–102.
  • BAST RC, FREENEY M, LAZARUS H et al.: Reactivity of a monoclonal antibody with human ovarian carcinoma. Clin. Invest. (1981) 68:1331–1337.
  • JACOBS I, BAST RC: Immunodiagnosis of ovarian tu-mors. In: Immunodiagnosis of Cancer. Heberman RB, Mer-cer DW (Eds.), Marcel Dekker, Inc., NY, USA (1986):323–338.
  • HOON DSB, IRIE RF, COCHRAN AJ: Gangliosides from human melanoma immunomodulate response of T cells to interleukin-2. Cell. Immunol. (1988) 111:410–419.
  • MYRTLE JF, SCHACKELFORD W, BARTHOLOMEW RM, WAMPLER J: Prostate specific antigen: quantitation in serum by immnoradiometric assay. Clin. Chem. (1983) 29:1216–1220.
  • LIEDTKE RJ, BATJER JD: Measurement of prostate-specific antigen by radioimmunoassay. Clin. Chem. (1984) 30:649–652.
  • KOHLER G, MILSTEIN C: Continuous cultures of fused cells secreting antibody of pre-defined specificity. Na-ture (1975) ???:495–498.
  • KEENAN AM, HARBERT JC, LARSON SM: Monoclonal an-tibodies in nuclear medicine. J. Nuclear Med. (1985) 26:531–540.
  • MEDELMAN MA, SHEALY DJ, BOULIN R et al. Rapid in- fant imaging with a Technitium-99m labeled anti-myosin recombinant single chain Fv: evaluation in a canine model of acute myocardial infarction. J. Nuclear Med. (1993) 34:234–241.
  • GRANZOW R, REED R: Interactions in the fourth dimen-sion. Biotechnology (1992) 10:390–395.
  • LISGARTEN MA, WONG MY, LAI CH: Detection of A. actinomycetemcomitans, Porphyromonas gingivalis, and Bacteroides forsythus in an A. actinomycetem-comitans positive patient population. J. Periodontal. (1995) 66:158–164.
  • LEVINE M, MOVAFAGH BF: Analysis of the specificity of natural human antibody reactive to Actinomyces. Mol. Immunol. (1986) 23:255–261.
  • LOSONSKY GA, HASAN JA, HUQ A, KAINTUCK S, COL-WELL RR: Serum antibody responses of divers to water-borne pathogens. Clin. Diagn. Lab. Immunol. (1994) 1:182–185.
  • POLLARD DR, JOHNSON WM, LIOR H, TYLER SD, ROZEEKR: Detection of the aerolysin gene in Aeromonas hy-drophila by the polymerase chain reaction. J. Clin. Mi-crobiol. (1990) 28:2477–2481.
  • LAOSRISIN N, MAKASHIMA K, ISHIKAWA I: Detection of Baceteroides gingivalis antigenic proteins by im-munoblotting analysis. J. Periodontal. (1990) 61:261–268.
  • KNOBLOCH J, BIALEK R, MULLER G, ASMUS P: Common surface epitope of Bartonelia bacilliformis and Chia- mydia psittaci.Trop. Med. Hyg. (1988) 39:427–433.
  • MAGNARELLI LA: Current status of laboratory diagnosis of lyme disease. Am. J. Med. (1995) 98:105–125.
  • CALLISTER SM, SCHELL RF, LIM LC: Detection of borrelio-cidal antibodies by flow cytometry. An accurate, highly specific serodiagnostic test for lyme disease. Arch. Intern. Med. (1994) 154:1625–1632.
  • BLASER MJ, DUNCAN DJ, OSTERHOLM MT, ISTRE GR, WANG WL: Serologic study of two clusters of infection due to Campylobacter jejuni. J. Infect. Dis. (1983) 147:820–823.
  • SCHWARTZ D, MELAMED I, COHEN D et al.: ELISA for Campylobacter jejuni antibodies in Israeli children with diarrhea and in healthy soldiers. Isr. J. Med. ScL (1990) 26:319–324.
  • JALGAONKAR SV, SAOJI AM: Coagglutination for rapid testing of toxin producing Corynebacterium diphthe-riae. Ind. J. Med. Res. (1993) 97:35–36.
  • YAM WC, LUNG ML, NG MH: Evaluation and optimiza-tion of latex agglutination assay for detection of chol-era toxin and Escherichia roll' heat-labile toxin. J. Clin. Microbiol. (1992) 30:2518–2520.
  • AITKEN R, HIRST TR: Development of an immunoassay using recombinant maltose-binding protein-STa fu-sions for quantitating antibody responses against STa, the heat stable enterotoxin of Escherichia cob'. J. Clin. Microbiol. (1992) 30:732–734.
  • SCHABER E, UMLAUFT F, STOFFLER G et al.: Indirect im-munofluorescence test and enzyme-linked immuno-sorbent assay for detection of Campylobacter pylori. J. Microbiol. (1989) 27:327–330.
  • BHARGAVA DK, DASARATHY S, SHRINIWAS DM et al.: Evaluation of enzyme-linked immunosorbent assay using mycobacterial saline-extracted antigen for the derodiagnosis of abdominal tuberculosis. Am] Castro-enterol (1992) 87:105–108.
  • CRAVEN RB: Plague. In: Infectious Diseases: A Treatise of Infectious Processes. Hoeprich PD, Jordan MC, Ronald AR (Eds.), JB Lippincott Co., Philadelphia, USA (1994):1302–1312.
  • SITHIGORNGUL P, STRETTON AOW, COWDEN C: A ver-satile dot-ELISA method with femtomole sensitivity for detecting small peptides. J. Immunol Methods (1991) 141:23–32.
  • ABDULLAH WO, OTHUMAN P, YUNUS H: Detection of circulating antigens and parasitic specific antibodies in filariasis. Southeast Asian J. Trop. Med. Public Health (1993) 24(2) :31–36.
  • WINIECKA-KRUSNELL J, UNDER E: Detection of Giardia lamblia cysts in stool samples by immunofluores-cence using monoclonal antibody. Eur. J. Clin. Micro-biol. Infect. Dis. (1995) 14:218–222.
  • SHETTY P, DILAWARI JB, VIRK KJ et al.: Enzyme-linked immunosorbent assay using excretory/secretory and somatic antigens as a diagnostic test for human hook-worm infection. Trans. R. Soc. Trop. Med. Hyg. (1988) 82:736–738.
  • KAR K: Serodiagnosis of leishmaniasis. Grit. Rev. Micro-biol. (1995) 21:123–152.
  • PAN AA, ROSENBERG GB, HURLEY MK et al.: Clinical evaluation of an EIA for the sensitive and specific de-tection of serum antibody to Trypanosoma cruzi (Cha-gas disease). J. Infect. Dis. (1992) 165:585–588.
  • RAMZY RMR, HELMY H, FARIS R et al.: Evaluation of a re-combinant antigen-based antibody assay for diagnosis of bancroftian filariasis in Egypt. Ann. Trop. Med. Para-sitol (1995) 89:443–446.
  • SOLOMON HE, GRANDIEN M, AVILA MM et al.: Compari-son of three techniques for detection of respiratory vi-ruses in nasopharyngeal aspirates from children with lower acute respiratory infections. J. Med. Virol. (1989) 28:159–162.
  • WOOD DJ, BIJLSMA K, DEJONG J et al.: Evaluation of a commercial monoclonal antibody-based enzyme im-munoassay for detection of adenovirus types 40 and 41 in stool specimens. J. Clin. Microbiol (1989) 27:1155–1158.
  • MILLER H, MCCULLOCH B, LANDINI MP, ROSSIER E: Com-parison of immunoblotting with other serological methods and virus isolation for the early detection of primary cytomegalovirus infection in allograft recipi-ents. J. Clin. Microbiol. (1989) 27:2672–2677.
  • STAGNO S, TINKER MK, ELROD C etal.: Immunoglobulin M antibodies detected by enzyme-linked immuno-sorbent assay and radioimmunoassay in the diagnosis of cytomegalovirus infections in pregnant women and newborn infants. J. Clin. Microbiol. (1985) 21:930–935.
  • CALISHER CH, MONATH TP: Togaviridae and Flaviviri-dae: the alphaviruses and flaviviruses. In: Laboratory Diagnosis of Infectious Diseases: Principles and Practices. Lennette E, Halonen PE, Murphy FA (Eds.), Springer Verlag, New York, USA (1988):414–434.
  • KSIAZEK TG, ROLLIN PE, JAHRLING PB et al: Enzyme im-munosorbent assay for Ebola virus antigen in tissues of infected primates. J. Clin. Microbiol (1992) 30:947–950.
  • SMITH RS, RHODES G, VAUGHAN JH et al: A synthetic peptide for detecting antibodies to Epstein-Barr virus nuclear antigen in sera from patients with infectious mononucleosis. J. Infect. Dis. (1986) 154:885–889.
  • DAMEN M, ZAAIJER HL, CUYPERS HTM et al: Reliability of the third generation recombinant immunoblot as-say for hepatitis C virus. Transfusion (1995) 35:745–749.
  • KLINE RL, BROTHERS T, HALSEY N et al: Evaluation of enzyme immunoassays for antibody to human T-lymphotropic viruses Type I/II. Lancet (1991) 337:30–33.
  • LAL RB, BRODINE S, KAZURA J et al: Sensitivity and specificity of a recombinant transmembrane glyco-protein (rgp21)-spiked Western immunoblot for sero-logical confirmation of human T-cell lymphotropic virus Type I and Type II infections. J. Clin. Microbic)]. (1992) 30:296–299.
  • BOYD AS: Laboratory testing in patients with morbilli-form viral eruptions. Dermatol Clin. (1994) 12:69–82.
  • PETIT C, MINNICH LL, SHEHAB ZM, RAY CG: Comparison between indirect immunofluorescence and microneu-tralization for detection of antibodies to polioviruses. j Gun. Microbiol. (1987) 25:1325–1326.
  • WHITLE H, HAZLETT D, WOOD D, BELLE: Immunofluo-rescence technique for the identification of poliovi-ruses. Lancet (1992) 339:429–430.
  • MATTER L, GORGIEVSKI-HRISOHO M, GERMANN D: Comparison of four enzyme immunoassays for detection of immunoglobulin M antibodies against ru- bella virus. J. Gun. Microbiol. (1994) 32:2134–2139.
  • HEALY GR: Immunologic tools in the diagnosis of ame-biasis: epidemiology in the United States. Rev. Infect. Dis. (1986) 8:239–246.
  • DIETZE R, PERKINS M, BOULOS M et al.: The diagnosis of Plasmodium falciparum infection using a new anti-gen detection system. Am. J. Trop. Med. Hyg. (1995) 52:45–49.
  • NUSSLEIN HG, ZIMMERMANN T, BAUM et al: Improved in vitro diagnosis of allergy to Alternaria tenius and Cladosporium herbarum. Allergy (1987) 42:414–422.
  • JONES JM: Laboratory diagnosis of invasive candidia-sis. Clin. Microbiol. Rev. (1990) 3:32–45.
  • COOK PJ, HONEYBOURNE D: Chlamydia pneumoniae. I Antimicrob. Chemother. (1994) 34:859–873.
  • MARRIE TJ, GRAYSON JT, WANG SP, KUO CC: Pneumo-nia associated with the TWAR strain of Chlamydia. Ann. Intern. Med. (1987) 106:507–511.
  • TEE, RD, GORDON DJ, TAYLOR AJ: Cross-reactivity be-tween antigens of fungal extracts studied by RAST inhi-bition and immunoblot technique. J. Allergy Clin. Immunol. (1987) 42:414–422.
  • VILLALBA E: Detection of antibodies in the sera of pa-tients with chromboblastomycosis by counter immu-noelectrophoresis. I. Preliminary results. J. Med. Vet. Mycol. (1988) 26:73–74.
  • KOSHI G, ANANDI V, SHASTRY JCM et al.: Coagglutina-tion (coa) test for the rapid diagnosis of cryptococcal meningitis. J. Med. Microbiol (1989) 29:189–194.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.